Browsing Tag
Lumos Diagnostics
6 posts
Lumos Diagnostics Holdings Limited puts FebriDx US rollout at centre of ASX:LDX rerating test
Find out how Lumos Diagnostics Holdings is using FebriDx US adoption to test whether ASX:LDX can turn regulatory wins into revenue.
Lumos Diagnostics (ASX: LDX) wins full U.S. Medicare reimbursement for FebriDx
Lumos Diagnostics secures full Medicare MAC reimbursement for FebriDx, opening doors to U.S. healthcare adoption. Find out what’s next for LDX shares.
Lumos Diagnostics shares surge 155% on ASX after $317m U.S. FebriDx deal with PHASE Scientific
Lumos Diagnostics surges 155% after securing a $487M U.S. FebriDx deal with PHASE Scientific. Find out what this means for investors in 2025.
Lumos Diagnostics (ASX: LDX) reaches 500-patient milestone in FebriDx CLIA study
Lumos Diagnostics hits a key 500-patient milestone in its FebriDx CLIA waiver study, triggering BARDA funds. FDA application expected by October 2025.
Lumos Diagnostics receives FDA EUA for ViraDx Rapid POC Test
Lumos Diagnostics (ASX: LDX) has announced that its ViraDx test has been granted Emergency Use Authorization (EUA) and…
Lumos Diagnostics, Henry Schein sign distribution deal for FebriDx Test in Iberia
Lumos Diagnostics (ASX: LDX), a leading name in rapid, point-of-care diagnostic technologies, has entered into a distribution agreement…